Science Explorer Back to mapMap
Discussion
Company · Macquarie Park · Australia

Teva Pharmaceuticals (Australia)

tevapharm.comROR OpenAlex
Research works
29
▼ 27% vs 2018-21
Citations
363
12.6 per fractional work
Top-10% rate
3.2%
all institutions 10.0%
Open access
43%
world 40%
International
70%
world 18%
Teva Pharmaceuticals (Australia)

Not ranked overall: Teva Pharmaceuticals (Australia) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Teva Pharmaceuticals (Australia) work in?

In all years, 66% of research at Teva Pharmaceuticals (Australia) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (62%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (7%). It does 2.3× the world's share of Health Sciences.

Health Sciences: 19 fractional works · 66.2% of its workMedicine: 18 fractional works · 62.4% of its workPsychiatry and Mental health: 4 fractional works · 15.0% of its workOncology: 2 fractional works · 6.5% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 6.2% of its workPathology and Forensic Medicine: 1 fractional works · 4.3% of its workSurgery: 1 fractional works · 3.7% of its workEpidemiology: 1 fractional works · 3.1% of its workPhysiology: 1 fractional works · 2.9% of its workFamily Practice: 1 fractional works · 2.9% of its workRheumatology: 1 fractional works · 2.6% of its workNeurology: 1 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.7% of its workHematology: 0 fractional works · 1.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.1% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.0% of its workGastroenterology: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.9% of its workGeriatrics and Gerontology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.6% of its workOphthalmology: 0 fractional works · 0.6% of its workDermatology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 2.9% of its workSpeech and Hearing: 0 fractional works · 1.5% of its workEmergency Medical Services: 0 fractional works · 0.9% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.6% of its workNutrition and Dietetics: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workLife Sciences: 7 fractional works · 24.1% of its workImmunology and Microbiology: 2 fractional works · 7.2% of its workImmunology: 2 fractional works · 6.6% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.6% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 6.9% of its workMolecular Biology: 2 fractional works · 5.4% of its workGenetics: 0 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.2% of its workCancer Research: 0 fractional works · 0.2% of its workAging: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 5.5% of its workCellular and Molecular Neuroscience: 1 fractional works · 2.8% of its workNeurology: 0 fractional works · 1.3% of its workSensory Systems: 0 fractional works · 0.8% of its workBiological Psychiatry: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.4% of its workToxicology: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.8% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 1 fractional works · 2.1% of its workPlant Science: 0 fractional works · 0.8% of its workFood Science: 0 fractional works · 0.7% of its workInsect Science: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 6.5% of its workEconomics, Econometrics and Finance: 1 fractional works · 4.7% of its workEconomics and Econometrics: 1 fractional works · 4.7% of its workPsychology: 0 fractional works · 0.9% of its workClinical Psychology: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workSocial Sciences: 0 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.6% of its workHealth: 0 fractional works · 0.3% of its workPhysical Sciences: 1 fractional works · 3.3% of its workEnvironmental Science: 0 fractional works · 1.3% of its workEcology: 0 fractional works · 0.7% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.3% of its workPollution: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEngineering: 0 fractional works · 0.8% of its workBiomedical Engineering: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.6% of its workPolymers and Plastics: 0 fractional works · 0.6% of its workALL ITS WORKTevaPharmaceuticals…29fractional works, all years
Life Sciences24%Physical Sciences3%Health Sciences66%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine1862.4%
    2. Health Professions12.9%
    3. Nursing00.6%
    4. Veterinary00.3%
    1. Immunology and Microbiology27.2%
    2. Biochemistry, Genetics and Molecular Biology26.9%
    3. Neuroscience25.5%
    4. Pharmacology, Toxicology and Pharmaceutics12.4%
    5. Agricultural and Biological Sciences12.1%
    1. Economics, Econometrics and Finance14.7%
    2. Psychology00.9%
    3. Social Sciences00.9%
    1. Environmental Science01.3%
    2. Engineering00.8%
    3. Chemistry00.6%
    4. Materials Science00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.69× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.86× its world share, 0 worksImmunology and Micro…Neuroscience: 5.07× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.05× its world share, 0 worksPharmacology, Toxico…Engineering: 0.08× its world share, 0 worksEngineeringEnvironmental Science: 0.54× its world share, 0 worksEnvironmental ScienceMedicine: 2.92× its world share, 5 worksMedicineNursing: 3.62× its world share, 0 worksNursingEconomics, Econometrics and Finance: 5.29× its world share, 1 worksEconomics, Econometr…Psychology: 0.77× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.1×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics8.05×0 works
  2. Economics, Econometrics and Finance5.29×1 works
  3. Neuroscience5.07×1 works
  4. Immunology and Microbiology3.86×0 works
  5. Nursing3.62×0 works
  6. Medicine2.92×5 works
  7. Biochemistry, Genetics and Molecular Biology1.69×1 works
  8. Psychology0.77×0 works
  9. Environmental Science0.54×0 works
  10. Agricultural and Biological Sciences0.11×0 works
  11. Engineering0.08×0 works

Who are the top researchers at Teva Pharmaceuticals (Australia)?

Ranked on the quality score, Anthony Doyle lead among researchers whose main affiliation is Teva Pharmaceuticals (Australia).

  1. 1 Anthony Doyle Australia · #2,568,960 worldwide 1.1k citations · 28 works
All ranked researchers at Teva Pharmaceuticals (Australia)

What are the most cited papers from Teva Pharmaceuticals (Australia)?

The most cited paper from Teva Pharmaceuticals (Australia) is "Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population" (Kiymet Bozaoglu, David H. Segal, Katherine A. Shields et al., 2009), with 262 citations. Next come "Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers" (159) and "BCR-ABL Messenger RNA Levels Continue to Decline in Patients with Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib for More Than 5 Years and Approximately Half of All First-Line Treated Patients Have Stable Undetectable BCR-ABL Using Strict Sensitivity Criteria" (143).

Most cited papers
#PaperReleasedCitations
1 Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population Kiymet Bozaoglu, David H. Segal, Katherine A. Shields et al. · The Journal of Clinical Endocrinology & Metabolism Open access 27 May 2009 262
2 Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers C. Glenn Begley et al. · Science Translational Medicine Open access 22 Sep 2021 159
3 BCR-ABL Messenger RNA Levels Continue to Decline in Patients with Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib for More Than 5 Years and Approximately Half of All First-Line Treated Patients Have Stable Undetectable BCR-ABL Using Strict Sensitivity Criteria Susan Branford, John Francis Seymour, Andrew Grigg et al. · Clinical Cancer Research Dec 2007 143
4 Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes Imogen Moran, Akira Nguyen, Weng Hua Khoo et al. · Nature Communications Open access 16 Aug 2018 119
5 The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study Jennifer Arnold, Caroline M. Markey, Nicol Kurstjens et al. · BMC Ophthalmology Open access 23 Mar 2016 101
All 83 most cited papers, with filters and sorting

Which keywords describe research at Teva Pharmaceuticals (Australia)?

By fractional works in all years, weighted toward what it does more of than the world: Neurological Disorders, Headache Disorders, Migraine, Epidemiology, Quality of Life, Treatment, Cost-effectiveness Analysis and Health Utility Measures.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 12 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 12 words, with their numbers
  1. Neurological Disorders5▲ 24×9 topics
  2. Headache Disorders4▲ 516×1 topic
  3. Migraine4▲ 282×1 topic
  4. Epidemiology3▲ 2.6×19 topics
  5. Inflammation2▲ 2.8×11 topics
  6. Quality of Life2▲ 5.0×5 topics
  7. Treatment2▲ 4.6×11 topics
  8. Cost-effectiveness Analysis1▲ 58×1 topic
  9. Health Utility Measures1▲ 58×1 topic
  10. Clinical Trials1▲ 6.1×8 topics
  11. Monoclonal Antibodies1▲ 26×2 topics
  12. Oxidative Stress1▲ 1.98×10 topics

Which research topics does Teva Pharmaceuticals (Australia) publish most on?

By volume in 2022-now: Health Systems, Economic Evaluations, Quality of Life, Genetic Neurodegenerative Diseases, Migraine and Headache Studies and Radiopharmaceutical Chemistry and Applications.

Health Systems, Economic…1Health Systems, Economic Evaluations, Quality of Life: 1 fractional worksGenetic Neurodegenerative Diseases: 1 fractional worksMigraine and Headache Studies: 1 fractional worksRadiopharmaceutical Chemistry and Applications: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksMultiple Sclerosis Resea…0Multiple Sclerosis Research Studies: 0 fractional worksPeptidase Inhibition and Analysis: 0 fractional worksOphthalmology and Visual Impairment Studies: 0 fractional worksTrace Elements in Health: 0 fractional worksRetinal Development and Disorders: 0 fractional works
Economics and EconometricsCellular and Molecular NeurosciencePsychiatry and Mental healthRadiology, Nuclear Medicine and Imaging5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  2. 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 1 works
  3. 3 Migraine and Headache Studies Psychiatry and Mental health 1 works
  4. 4 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 0 works
  7. 7 Peptidase Inhibition and Analysis Oncology 0 works
  8. 8 Ophthalmology and Visual Impairment Studies Epidemiology 0 works
  9. 9 Trace Elements in Health Nutrition and Dietetics 0 works
  10. 10 Retinal Development and Disorders Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.6%not open57.4%

World: 40% of research is openly available.

with international co-authors70.5%domestic only29.5%

World: 18% is written across borders.

How has Teva Pharmaceuticals (Australia)'s research output changed?

Output in 2022-2025 was 27% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Teva Pharmaceuticals (Australia) as a percentage of every work published that year, 0.000026% in 2024.

still counting0.000050%0.00010%0.00015%Teva Pharmaceuticals (Australia)0.000037% in 20251990200020102020

Fractional works of Teva Pharmaceuticals (Australia) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Macquarie Park

All research institutions in Macquarie Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Teva Pharmaceuticals (Australia). Posts are plain text and can be reported.